Diabetes Channel
Topics
Medications
Quicklinks
Related Channels
Invokana Uses

Related Multimedia
Click on an icon to view.Invokana is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. Normally, the kidneys filter glucose (sugar) out of the blood and into the urine. However, SGLT transporters help this glucose to be reabsorbed back into the blood in the kidneys. Essentially, the kidneys filter out and then "reclaim" the glucose.
Invokana inhibits one of the types of these transporters, preventing the kidneys from reabsorbing the glucose. This leads to glucose loss through the urine.
This drug is not approved for use in children (defined as individuals younger than 18 years old). Talk with your child's healthcare provider about the benefits and risks of using this medication in children.
On occasion, your healthcare provider may recommend this medication for treating something other than type 2 diabetes. This is called an "off-label" use. At this time, there are no well-accepted off-label uses for Invokana.
Written by/reviewed by: Kristi Monson, PharmD
Last reviewed by: Kristi Monson, PharmD